Pfizer to absorb Mylan Pharmaceuticals
Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic... |!| Bridgeport
Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic... |!| Bridgeport